发布求助
文献互助 智能选刊 最新文献

Farmaceuticos Comunitarios最新文献

筛选
英文 中文
[Pharmaceutical Indication Service in a case of palmar-plantar erythema after amoxicillin and ibuprofen treatment]. [阿莫西林和布洛芬治疗后掌跖红斑病例中的 "药用说明服务"]。
IF 0.6
Farmaceuticos Comunitarios Pub Date : 2024-09-19 eCollection Date: 2024-10-15 DOI: 10.33620/FC.2173-9218.(2024).22
Lola Parra-Astorgano
{"title":"[Pharmaceutical Indication Service in a case of palmar-plantar erythema after amoxicillin and ibuprofen treatment].","authors":"Lola Parra-Astorgano","doi":"10.33620/FC.2173-9218.(2024).22","DOIUrl":"https://doi.org/10.33620/FC.2173-9218.(2024).22","url":null,"abstract":"<p><strong>Case description: </strong>Patient (29 years old) with palmo-plantar erythema, goes to the community pharmacy (FC) requesting a cream to treat atopy.</p><p><strong>Evaluation: </strong>The patient accessed the Pharmaceutical Indication Service (SPIF), showing that the manifestations appeared 24 hours after the start of dental treatment with amoxicillin 1g/12h and ibuprofen 600 mg/8h without any concomitant medication.</p><p><strong>Intervention: </strong>After explaining the possible relationship of the symptoms with their medication, patient was derived to the doctor with the referral report completed by SEFAC-eXPERT.</p><p><strong>Results: </strong>The patient went to the emergency where she was treated with intravenous corticosteroid and a prescription for cetirizine 10 mg. The dentist changed the beta-lactam to a macrolide (azithromycin) and the ibuprofen to paracetamol. From the FC, the evolution of the symptoms was monitored, which took 72 hours to disappear. Allergy tests suggested avoiding beta-lactams, cephalosporins, and arylpropionics without being conclusive. Months later, the patient suffered similar symptoms after inhaling a disinfectant spray and the allergy diagnosis was confirmed.</p><p><strong>Conclusions: </strong>The FC identified and immediately referred using SPIF a case of hypersensitivity in a patient susceptible to RNM and the SPIF helps to record the intervention and follow-up, increasing patient safety.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"16 4","pages":"83-87"},"PeriodicalIF":0.6,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11491920/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Role of the Pharmacotherapeutic Monitoring Service (PMS) of the Community Pharmacy in the detection and resolution of adverse reactions to statins linked to possible diagnostic errors in elderly patients]. [社区药房的药物治疗监测服务（PMS）在发现和解决与老年患者可能的诊断错误有关的他汀类药物不良反应中的作用]。
IF 0.6
Farmaceuticos Comunitarios Pub Date : 2024-09-17 eCollection Date: 2024-10-15 DOI: 10.33620/FC.2173-9218.(2024).21
Diana Laura García Martín
{"title":"[Role of the Pharmacotherapeutic Monitoring Service (PMS) of the Community Pharmacy in the detection and resolution of adverse reactions to statins linked to possible diagnostic errors in elderly patients].","authors":"Diana Laura García Martín","doi":"10.33620/FC.2173-9218.(2024).21","DOIUrl":"10.33620/FC.2173-9218.(2024).21","url":null,"abstract":"<p><strong>Introduction: </strong>The Medication Review in the Pharmacotherapeutic Follow-up Service (PFS) seems to be an effective method to study long-term drug safety in the outpatient setting. The adverse drug reactions (ADRs) that are not immediately obvious are difficult to identify and sometimes can be confused with a more common condition. Misdiagnosis by not associating the symptoms of AMR to its pharmacological cause causes its masking and hinders its detection.</p><p><strong>Objective: </strong>Detect in the SFT service the diagnostic errors related to the non-detection of adverse reactions to statins.</p><p><strong>Material and methods: </strong>The data obtained from the medication review at the Pharmacotherapeutic Follow-up Service (PFS) were pooled for analysis. The patients who received the service were selected with the \"DLGM screening\" tool, an acronym \"Diagnosis load Generated by Medications\", that allows us to describe adverse drug reactions (ADRs), when their symptoms are attributed to a pathology, without considering medication as a possible underlying cause.Only the results of patients over 60 years of age, who after a prolonged period of statin use gradually presented musculoskeletal disorders (MSD) and other symptoms theoretically described as possible ADRs, are shown.</p><p><strong>Results: </strong>In 66 % of the cases, corresponding to 14 patients out of a total of 21 studied, the physician modified the treatment and in 92% of these cases there was improvement and a decrease of the consumption of analgesics drug, anti-inflammatory and other drugs used to treat ADR symptoms.</p><p><strong>Conclusion: </strong>DLGM screening identified hidden AMRs in 62 % of patients.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"16 4","pages":"5-14"},"PeriodicalIF":0.6,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11491921/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Selection of pharmacogenomic variants and methodology for their use in community pharmacy]. [药物基因组变体的选择及其在社区药房使用的方法]。
IF 0.6
Farmaceuticos Comunitarios Pub Date : 2024-09-17 eCollection Date: 2024-10-15 DOI: 10.33620/FC.2173-9218.(2024).27
A Montero-Gómez, A Sánchez Pozo
{"title":"[Selection of pharmacogenomic variants and methodology for their use in community pharmacy].","authors":"A Montero-Gómez, A Sánchez Pozo","doi":"10.33620/FC.2173-9218.(2024).27","DOIUrl":"10.33620/FC.2173-9218.(2024).27","url":null,"abstract":"<p><p>Regulatory agencies such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) recognize pharmacogenetics as a key tool in their pharmacological guidelines for pharmaceutical counseling. In this context, community pharmacies play a crucial role in addressing this healthcare need, which could lead to a significant improvement in patients' quality of life by preventing ineffective or contraindicated treatments.In this work, we conducted a systematic review of the available scientific evidence regarding druggene interactions relevant to community pharmacy. We identified the main genes and polymorphisms associated with treatment response and adverse effects in primary care. Finally, we propose a model for implementing pharmacogenetic services in community pharmacies.</p>","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"16 4","pages":"61-82"},"PeriodicalIF":0.6,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11491914/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142509938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Material para farmacéuticos. Citisiniclina. Porque lo Natural es dejar de fumar, hay manera de ayudar a tus pacientes 制药材料。Citisiniclina。因为戒烟很自然，所以有办法帮助你的病人
Farmaceuticos Comunitarios Pub Date : 2023-10-20 DOI: 10.33620/fc.2173-9218.(2023).ifg.072
{"title":"Material para farmacéuticos. Citisiniclina. Porque lo Natural es dejar de fumar, hay manera de ayudar a tus pacientes","authors":"","doi":"10.33620/fc.2173-9218.(2023).ifg.072","DOIUrl":"https://doi.org/10.33620/fc.2173-9218.(2023).ifg.072","url":null,"abstract":"","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"160 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abordaje conjunto Médico – Farmacéutico del paciente con Trastorno Depresivo. Guía de Actuación 抑郁症患者的医学-药物联合治疗。行动指南
Farmaceuticos Comunitarios Pub Date : 2023-10-20 DOI: 10.33620/fc.2173-9218.(2023).ifg.076
{"title":"Abordaje conjunto Médico – Farmacéutico del paciente con Trastorno Depresivo. Guía de Actuación","authors":"","doi":"10.33620/fc.2173-9218.(2023).ifg.076","DOIUrl":"https://doi.org/10.33620/fc.2173-9218.(2023).ifg.076","url":null,"abstract":"","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infografía para pacientes: ¿Obesidad infantil? 患者信息图:儿童肥胖?
Farmaceuticos Comunitarios Pub Date : 2023-10-20 DOI: 10.33620/fc.2173-9218.(2023).ifg.074
{"title":"Infografía para pacientes: ¿Obesidad infantil?","authors":"","doi":"10.33620/fc.2173-9218.(2023).ifg.074","DOIUrl":"https://doi.org/10.33620/fc.2173-9218.(2023).ifg.074","url":null,"abstract":"","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infografía para farmacéuticos: ANTIDIABÉTICOS ORALES. DESCUBRE SU FARMACOGENÉTICA 药剂师信息图:口服降糖药。发现你的药物遗传学
Farmaceuticos Comunitarios Pub Date : 2023-10-20 DOI: 10.33620/fc.2173-9218.(2023).ifg.078
{"title":"Infografía para farmacéuticos: ANTIDIABÉTICOS ORALES. DESCUBRE SU FARMACOGENÉTICA","authors":"","doi":"10.33620/fc.2173-9218.(2023).ifg.078","DOIUrl":"https://doi.org/10.33620/fc.2173-9218.(2023).ifg.078","url":null,"abstract":"","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Material para pacientes. Citisiniclina. Porque lo Natural es dejar de fumar 病人的材料。Citisiniclina。因为戒烟是很自然的事
Farmaceuticos Comunitarios Pub Date : 2023-10-20 DOI: 10.33620/fc.2173-9218.(2023).ifg.073
{"title":"Material para pacientes. Citisiniclina. Porque lo Natural es dejar de fumar","authors":"","doi":"10.33620/fc.2173-9218.(2023).ifg.073","DOIUrl":"https://doi.org/10.33620/fc.2173-9218.(2023).ifg.073","url":null,"abstract":"","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"188 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infografía para pacientes: La Importancia de la Vacunación en el adulto, ¿Te apuntas al reto? 患者信息图:成人接种疫苗的重要性，你加入挑战了吗?
Farmaceuticos Comunitarios Pub Date : 2023-10-20 DOI: 10.33620/fc.2173-9218.(2023).ifg.077
{"title":"Infografía para pacientes: La Importancia de la Vacunación en el adulto, ¿Te apuntas al reto?","authors":"","doi":"10.33620/fc.2173-9218.(2023).ifg.077","DOIUrl":"https://doi.org/10.33620/fc.2173-9218.(2023).ifg.077","url":null,"abstract":"","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infografía para farmacéuticos: Farmacogenética en Anticoagulantes: Una Guía Básica para Farmacéuticos Comunitarios 药剂师信息图:抗凝药物的药物遗传学:社区药剂师的基本指南
Farmaceuticos Comunitarios Pub Date : 2023-10-20 DOI: 10.33620/fc.2173-9218.(2023).ifg.075
{"title":"Infografía para farmacéuticos: Farmacogenética en Anticoagulantes: Una Guía Básica para Farmacéuticos Comunitarios","authors":"","doi":"10.33620/fc.2173-9218.(2023).ifg.075","DOIUrl":"https://doi.org/10.33620/fc.2173-9218.(2023).ifg.075","url":null,"abstract":"","PeriodicalId":40648,"journal":{"name":"Farmaceuticos Comunitarios","volume":"54 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135665573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信